Concepedia

Jaume Vidal

JV

Statistics

Publications

6

Citations

1.1K

H-Index

6

Active since

2007

Affiliations

GlaxoSmithKline (Spain)(Current)

GlaxoSmithKline (United States)

GlaxoSmithKline (France)

Research Triangle Park Foundation

Medicines for Malaria Venture

Jaume Vidal is an author at GlaxoSmithKline (Spain) specializing in antimalarial agents, antimalarial drug development, and medicinal chemistry.

Publications per year

2007–2017

6

Publications

6

Thousands of chemical starting points for antimalarial lead identification

Francisco‐Javier Gamo, Laura M. Sanz, Jaume Vidal et al. · Nature · 2010 · 1K citations

, , +12

Potent antimalarial 4-pyridones with improved physico-chemical properties

José M. Bueno, Pilar Manzano, María C. García et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 40 citations

, , +12

Design, Synthesis, and in Vitro Activity of Novel 2′-<i>O</i>-Substituted 15-Membered Azalides

Dijana Pešić, Kristina Starčević, Ana Toplak et al. · Journal of Medicinal Chemistry · 2012 · 40 citations

, , +16

Individual-based model and simulation of Plasmodium falciparum infected erythrocyte in vitro cultures

Jordi Ferrer, Jaume Vidal, Clara Prats et al. · Journal of Theoretical Biology · 2007 · 17 citations

, , +16

Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives

María J. Chaparro, Jaume Vidal, Íñigo Angulo‐Barturen et al. · ACS Medicinal Chemistry Letters · 2014 · 13 citations

, , +16

1–5 of 6